MENU

Fox Chase Medical Physicist Receives Outstanding Leadership Award on behalf of Scientists for Accurate Radiation Information

March 22, 2016

2016 Award to SARI accepted by Mohan Doss (left) from Ed Calabrese, April 19, 20162016 Award to SARI accepted by Mohan Doss (left) from Ed Calabrese, April 19, 2016PHILADELPHIA (March 22, 2016) — Mohan Doss, PhD, MCCPM, one of the leading proponents of cancer prevention and treatment using low-dose radiation from Fox Chase Cancer Center, will receive the Outstanding Leadership Award in the field of dose-response on behalf of Scientists for Accurate Radiation Information at the 15th Annual International Conference of the International Dose-Response Society in Amherst, MA.

“I am honored to receive this award on behalf of Scientists for Accurate Radiation Information (SARI),” said Doss, one of the founding members of SARI, and associate professor and medical physicist at Fox Chase. SARI has taken several initiatives to correct the misinformation about the health effects of low-dose radiation. We in SARI are pleased to receive this recognition of our efforts. Part of our mission at SARI is to help prevent unnecessary, radiation phobia-related deaths, morbidity, and injuries associated with distrust of radio-medical diagnostics/therapies.”

Outstanding Leadership Award in the field of Dose-Response presented to Scientists for Accurate RadiationOutstanding Leadership Award in the field of Dose-Response presented to Scientists for Accurate RadiationDoss obtained his MS and PhD degrees in physics from Carnegie-Mellon University in Pittsburgh. After 10 years of post-doctoral research in the U.S. and Canada, he became a medical physicist in the Nuclear Medicine department of Regina General Hospital in Regina, Canada. In 2001, he joined the Diagnostic Imaging department of Fox Chase Cancer Center in Philadelphia, where he is presently an associate professor. Doss has board certification in Nuclear Medicine Physics from the Canadian College of Physicists in Medicine.

Doss also individually received the 2014 Outstanding Leadership Award in the field of dose-response from the International Dose-Response Society.

       

The Hospital of Fox Chase Cancer Center and its affiliates (collectively “Fox Chase Cancer Center”), a member of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship and community outreach. 
For more information, call 1-888-FOX CHASE or (1-888-369-2427).

Connect with Fox Chase